(Left:) Stock image of Ozempic; (Right:) Stock image of someone taking a bottle of alcohol off a shelf. A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide ...

DEAR PEOPLE’S PHARMACY: I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were all out of stock. I lost 17 pounds and my A1C went ...

Every sip you skip could be the first step toward a healthier, sharper, and more energetic version of you. Struggling to quit alcohol is a deeply personal and often difficult challenge, but it’s a ...

For the first time, scientists have shown that tirzepatide—the main ingredient in the diabetes and weight‑loss drug ...

2/20/25 (LAPost.com) — New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption. The study, published in JAMA ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise benefits besides shedding pounds soon surfaced. One of those – that the ...

It has been theorized that Ozempic could potentially help with substance abuse disorders due to the way it works in the brain. Now the first clinical study on the potential link suggests that the drug ...